Insulin pens are developed to address specific needs of diabetes patients for their pens, such as ease of use, portability, and discreetness. Like many consumer-based products, the development of insulin pens can pose significant challenges to the development team in that they must balance substantial accuracy requirements with aesthetic desires. The HumaPen® Memoir™ team learned valuable lessons throughout the development process that may be worth highlighting. A keen understanding of the unmet needs of the patient population and a skillfully planned product generation map are critical to successful device development. A development team must decide whether to use a Quality Functional Deployment or system engineering-based development plan and, additionally, recognize where proof of concept ends and product development begins to maintain a strict timeline for the project. A proficiency in understanding and managing technical risk is critical to ensure a timely and high-quality product launch to the marketplace. © Diabetes Technology Society.
CITATION STYLE
Breslin, S. D., Ignaut, D. A., & Boyd, D. E. (2010). Lessons learned during the development of HumaPen® MemoirTM,, aninsulin pen with a memory feature. In Journal of Diabetes Science and Technology (Vol. 4, pp. 540–546). SAGE Publications Inc. https://doi.org/10.1177/193229681000400306
Mendeley helps you to discover research relevant for your work.